Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

GuadeloupeBack to Guadeloupe

Clinical trials in Pointe A Pitre

2 clinical trials in Pointe A Pitre, Guadeloupe. Every trial is listed in the EU Clinical Trials Register and updated daily.

Pointe A Pitre at a glance
2
clinical trials
  • Recruiting now0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

2 trials in Pointe A Pitre

Open in trial search

Haemophagocytic lymphohistiocytosis

Not yet recruiting
Registered drug
Countries:GuadeloupeGuadeloupe
  • Participants:18–64 years · 65+ years
  • Substances:Etoposide
  • Sponsor:Assistance Publique Hopitaux De Paris

Haemophagocytic lymphohistiocytosis

Not yet recruiting
Registered drug
Countries:GuadeloupeGuadeloupe
  • Participants:18–64 years · 65+ years
  • Substances:Etoposide
  • Sponsor:Assistance Publique Hopitaux De Paris

Clinical research in Pointe A Pitre

What the registry says about research in the country

01 Pointe A Pitre
Diseases and Pathological Conditions
Clinical research in Pointe A Pitre focuses on Diseases and Pathological Conditions, with an emphasis on a rare and serious inflammatory disorder. Hemophagocytic lymphohistiocytosis (HLH) as the main disease under study Investigation of how treatment timing may affect organ failure in severe illness Evaluation of treatment strategies used in intensive care settings These trials are designed to better understand how to manage severe HLH and improve outcomes for patients with rapidly worsening disease.
Back to GuadeloupeAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

ClinicalTrials.eu

Every clinical trial in Europe, in plain language.

Explore the full ecosystem of clinical research in Europe.

Search trials

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).